DIETARY SUPPLEMENTS IN THE MANAGEMENT OF HYPERTENSION AND DIABETES-A REVIEW

African Journal of Traditional, Complementary and Alternative Medicines

Volumn 11, Issue 3, 2014, Pages 248-258

  Afolayan, Anthony Jide ^a   Wintola, Olubunmi Abosede ^a  

^a UNIVERSITY OF FORT HARE   (South Africa)

Author keywords

blood glucose; Blood pressure; botanicals; minerals; vitamins

Indexed keywords

AMINO ACID;

ALTERNATIVE MEDICINE; BLOOD PRESSURE; CEREBROVASCULAR ACCIDENT; COMPLICATION; CONSTIPATION; DIABETES MELLITUS; DIABETIC COMPLICATION; DIABETIC PATIENT; DIARRHEA; DIETARY SUPPLEMENT; ERECTILE DYSFUNCTION; FATIGUE; GLUCOSE BLOOD LEVEL; HEADACHE; HEALTH CARE SYSTEM; HEART INFARCTION; HERBAL MEDICINE; HUMAN; HYPERTENSION; KIDNEY DISEASE; LIFE EXPECTANCY; METABOLIC DISORDER; MORBIDITY; MORTALITY; NAUSEA AND VOMITING; NONHUMAN; QUALITY OF LIFE; REVIEW; SIDE EFFECT; STOMACH PAIN; THERAPY; VEGETABLE; ANALYSIS; DIET SUPPLEMENTATION; FACTUAL DATABASE;

DATABASES, FACTUAL; DIABETES MELLITUS; DIETARY SUPPLEMENTS; HUMANS; HYPERTENSION;

EID: 84964314491     PISSN: None     EISSN: 25050044     Source Type: Journal    
DOI: 10.4314/ajtcam.v11i3.35     Document Type: Review

References (130)

1. Abeywardena, M.Y., and Patten, G.S. (2011). Role of omega 3 Long chain polyunsaturated fatty acids in reducing cardio-metabolic risk factors. End. Metabol. and Immune Disorder-Drug Target., 11 (3):232-246.
2. Afolayan, A.J., and Sunmonu, T O. (2010). In vivo studies on Antidiabetic plants used in South Africa Herbal medicine. J. Clin. Biochem. Nutri., 47: 98-106.
3. Althuis, M.D., Jordan, N.E., Ludington, E.A. and Wittes, J.T. (2002). Glucose and insulin responses to dietary chromium supplements: A meta-analysis. Am. J. Clin. Nutr., 76(1):148-155.
4. American Diabetes Association, “Standards of medical care for patients with diabetes mellitus (position statement),” Diabetes Care, vol. 20, no. 1, pp. 518– 520, 1997.
5. Anderson, J.W., Hanna, T.J., Xuejun, Peng B.S., and Kryscio, R.J. (2000). Whole grain food and heart disease risk. J Ame College of Nutri., 19 (3): 291-299.
6. Anderson, R.A., Evans, M.L., Ellis, G.R., Graham, J., Morris, K., Jackson, S.K., Lewis, M.J., Rees, A., and Frenneaux M.P. (2001). The relationships between post-prandial lipaemia, endothelial function and oxidative stress in healthy individuals and patients with type 2 diabetes. Atherosclerosis., 154: 475-483.
7. Appel, L.J., Brands, M.W., Daniels, S.R., Karanja, N., Elmer, P.J., and Sacks, F.M. (2006). Dietary approaches to prevent and treat hypertension. A scientific statement from the American Heart Association. Hypertension, 47:296-308.
8. Awoyemi, O.K., Ewa, E.E., Abdulkarim, I.A., and Adepoju AR. (2012). Ethnobotanical assessment of herbal plants in South-Western Nigeria. Acad. Res. Intern., 2 (3): 50-57.
9. Balk, E.M., Tatsioni, A., Lichtenstein, A.H., Lau, J., and Pittas, A.G. (2007). Effect of chromium supplementation on glucose metabolism and lipids: a systematic review of randomized controlled trials. Diabetes Care., 30(8):2154-2163.
10. Banerjee, S.K., and Maulik, S.K. (2002). Effect of garlic on cardiovascular disorders: A review. Nutri. Journal., 1: (1):4.
11. Barbagallo, M., Dominguez, L.J., Tagliamonte, M.R., Resnick, L.M., and Paolisso, G. (1999). Effect of vitamin E and glutathione on glucose metabolism: Role of magnesium. Hyper., 34: 1002-1006.
12. Bastaki, S. (2005). Review: Diabetes mellitus and its treatments. Int. J. Dia Metabol., 13: 111-134.
13. Beckman, J.A., Goldfine, A.B., Gordon, M.B., and Craeger, M.A. (2001). Ascorbate restores endothelium-dependent vasodilation impaired by acute hyperglycemia in humans. Circulation., 103:1618-1623.
14. Begon, S., Pickering, G., Eschalier, A., and Dubray, C. (2000). Magnesium and MK-801 have a similar effect in two experimental models of neuropathic pain. Brain. Res., 887:436-439.
15. Bellows, I., and Moore, R. (2012). Water-soluble vitamins: B-complex and vitamin C. Colorado State University, Cooperative Extension fact sheet No. 9.312.
16. Bendich, A., and Cohen, M. (1990). Vitamin B6 safety issues. Annals of New York Academy of Sci., 585:321-30.
17. Bhanot, S., Bryer-Ash, M., Cheung, A., and McNeill, J.H. (1994a). Bis (maltolato) oxovanadium (IV) attenuates hyperinsulinemia and hypertension in spontaneously hypertensive rats. Diabetes., 43:857-861.
18. Bhanot, S., McNeill, J.H., and Bryer-Ash, M. (1994b) Vanadyl sulfate prevent fructose-induced hyperinsulinemia and hypertension in rats. Hyperten., 23:308-312.
19. Boden, G., Chen, X., Ruiz, J., van Rossum, G.D.V., and Turco, S. (1996). Effects of vanadyl sulfate on carbohydrate and lipid metabolism in patients with non-insulin-dependent diabetes mellitus. Metabol., 45:1130-1135.
20. Bonadkdar, R.A., and Guarneri, E. (2005). Coenzyme Q10. American Family Physician, 72(6):1065-1069.
21. Burgess, E., Lewanczuk, R., Bolli, P., Chockalingam, A., Cutler, H., Taylor, G., and Hamet P. (1999). Recommendations on potassium, magnesium, and calcium. Can. Med. Ass., 160: (9) 35-45.
22. Cappuccio, F.P., Duneclift, S.M., Atkinson, R.W., and Cook, D.G. (2001). Use of alternative medicines in a multi-ethnic population. Ethnic and Dis., 11:11-18.
23. Carlson, S., Peng, N., Prasain, J.K., and Wyss, J.M. (2008). Effects of Botanical dietary supplements on cardiovascular, cognitive and metabolic function in males and females. Gender Med., 5: 76-90.
24. Carretero, O.A., and Oparil S. (2000). "Essential hypertension. Part I: definition and etiology". Circulation., 101 (3): 329–35.
25. Cefalu, W.T., and Hu, F.B. (2004). Role of chromium in human health and in diabetes. Diabetes Care, 27:2741-2751.
26. Cohen, N., Halberstasm, M., Slimovitch, P., Shammon, H., and Rosetti, L. (1995). Oral vanadyl sulfate improves hepatic and peripheral insulin sensitivity in patients with non-insulin-dependent diabetes mellitus. J. Clin. Invest., 95:2501-2509.
27. Collins, Q.F., Liu, H.Y., Pi, J., Liu, Z., Quon, M.J., and Cao, W. (2007). Epigallocatechin-3-gallate (EGCG), a green tea polyphenol, suppresses hepatic gluconeogenesis through 5-AMP activated protein kinase. J. Bio. Chem., 282(41):30143-30149.
28. Cusi, K., Cukier, S., DeFronzo, R.A., Torres, M., Puchulu, F.M., and Redondo, J.C. (2001). Vanadyl sulfate improves hepatic and muscle insulin sensitivity in type 2 diabetes. J. Clin. Endocrinol, Metab., 86: 1410-1417.
29. De Luis, D.A., Conde, R., Aller, R., Izaola, O., Gonzalez Sagrado, M., Perez Castrillon, J.L., Duenas A., and Romero, E. (2009). Effect of omega-3 fatty acids on cardiovascular risk factors in patients with type 2 diabetes mellitus and hypertriglyceridemia: an open study. Eur. Rev. Med. Pharmacol. Sci., 13: 51-55.
30. De Smet, P.A. (2000). Herbal remedies. New Engl. J. Med., 347:2046-2056.
31. Dey, L., Attele, A.S., and SuYuan, C. (2002). Alternative therapies for type 2 diabetes. Alt. Med. Rev., 7 (1): 45-48.
32. DSHEA. (1994). Dietery supplements Health and Education Act. www.wikipedia accessed on 11/04/2013.
33. Du, X.J., Fang, L., and Kiriazis, H. (2006). Sex dimorphism in cardiac pathophysiology: Experimental findings, hormonal mechanisms, and molecular mechanisms. Pharmacol. Ther., 111:434-475.
34. Dubick, M., and Omaye, S.T. (2001). Modification of atherogenesis and heart disease by grape wine and tea polyphenols. In: Wildman REC, ed. Handbook of nutraceuticals and functional foods. Boca Raton, FL: CRC Press, 235-260.
35. Egede, L.E., Ye, X., Zheng, D., and Silverstein, M.D. (2002). The prevalence and pattern of complementary and alternative medicine use in individuals with diabetes. Dia. Care., 25:324-329.
36. Ellis, J.M., Folkers, K., Minadeo, M., Vanbuskirk, R., Xia, L.J., and Tamagawa H. (1991). A deficiency of vitamin B6 is a plausible molecular basis of the retinopathy of patients with diabetes mellitus. Biochem. Biophy. Res. Comm., 179: 615-619.
37. Engelhart, M.J., Geerlings, M.I., Ruitenberg, A., van Swieten, J.C., Hofman, A., Witteman, J.C., and Breteler, M.M. (2002). Dietary intake of antioxidants and risk of Alzheimer disease. J. Am. Med. Ass., 287: 3223-3229.
38. Forman, J.P., Rimm, E.B., Stampfer, M.J., and Curhan, G.C. (2005). Folate intake and the risk of incident hypertension among US women. JAMA., 293:320-329.
39. Frankel, E.N., Kanner, J., German, J.B., Parks, E., and Kinsella, J.E. (1993). Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine. Lancet., 341:454-457.
40. Fukino, Y., Shimbo, M., Aoki, N., Okubo, T., and Iso, H. (2005). Randomized controlled trial for an effect of green tea consumption on insulin resistance and inflammation markers. J. Nutr. Sci. Vitaminol., 51(5):335–342.
41. Gaede, P., Poulson, H.E., Parving, H.H., and Pederson, O. (2001). Double-blind, randomised study of the effect of combined treatment with vitamin C and E on albuminuria in Type 2 diabetic patients. Diabet Med.; 18:756-760.
42. Goldfine, A.B., Simonson, D.C., Folli, F., Patti, M.E., and Kahn, C.R. (1995). Metabolic effects of sodium metavanadate in humans with insulin-dependent and non-insulin-dependent diabetes mellitus. J. Clin. Endocrinol. Metabol., 80:3311-20.
43. Gulla, J., and Singer, A.J. (2000). Use of alternative therapies among emergency department patients. Ann. Emerge. Med. 35: 226-228.
44. Gupta, R., and Guptha, S. (2010). Strategies for initial management of hypertension. Indian. J. Med. Res., 132: 531-542.
45. Halat, K.M., and Dennehy, C.E. (2003). Botanicals and dietary supplements in diabetic peripheral neuropathy. J. Am. Board. Family Pract., 16: 47-57.
46. Halsad, C.H. (2003). Dietary supplements and functional foods: 2 sides of a coin. American J. Clinic. Nutri., 77:1001-1007.
47. Hartweg, J., Farmer, A.J., Perera, R., Holman, R. R, and Neil, H.A. (2007). Meta-analysis of the effects of n-3 polyunsaturated fatty acids on lipoproteins and other emerging lipid cardiovascular risk markers in patients with type 2 diabetes. Diabetologia., 50(8):1593-1602.
48. Hartweg, J., Perera, R., Montori, V.M., Dinneen, S.F., Neil, A.H.A.W.N., and Farmer, A.J. (2008). Omega-3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus. Cochrane Database of Systematic Reviews; 2008. doi:10.1002/14651858.CD003205.pub2. Issue 1.Art. No.: CD003205.
49. Hodgson, J.M., Watts, G.F., Playford, D.A., Burke, V., and Croft, K.D. (2002). Coenzyme Q10 improves blood pressure and glycemic control: A controlled trial in subjects with type 2 diabetes. Eur. J. Clinic. Nutri., 56; 1137-1142.
50. Holt, R.I.G. (2004). Diagnosis, epidemiology and pathogenesis of diabetes mellitus: an update for psychiatrists. The British Journal of Psychiatry 184: 47-55 doi: 10.1192/bjp.
51. Hooper, L., Thompson, R.L., Harrison, R.A., Summerbell, C.D., Ness, A.R., Moore, H.J., Worthington, H.V., Durrington, P.N, Higgins, J.P.T., Capps, N.E., Riemersma, R.A., Ebrahim, S.B.J., and Davey Smith, G. (2006). Risks and benefits of omega-3 fats for mortality, cardiovascular disease and cancer: a systematic review. Achieves of British Med. Journal., 332:752-760.
52. Huisman, M., Kunst, A.E., Andersen, O., Bopp, M., Borgan, J.K., Borrell, C., Costa, G., Deboosere, P., Desplanques, G., Donkin, A., Gadeyne, S., Minder, C., Regidor, E., Spadea, T., Valkonen, T., and Mackenbach, J.P. (2004). Socio-economic inequalities in mortality among the elderly in 11 European populations. J. Epidemiol. Comm. Health., 58:468–475. International Diabetes Federation (2011).
53. Jacob, S., Henriksen, E.J., Schiemann, A.L., Simon, I., Clancy, D.E., Tritschler, H.J., Jung, W.I., Augustin, H.J., and Dietze, G.J. (1995). Enhancement of glucose disposal in patients with type 2 diabetes by alpha-lipoic acid. Arzneimittel-Forschung., 45(8): 872-874.
54. Jacob, S., Henriksen, E.J., Tritschler, H.J., Augustin, H.J., and Dietze, G.J. (1996). Improvement of insulin-stimulated glucose-disposal in type 2 diabetes after repeated parenteral administration of thioctic acid. Exp. Clin. Endocrinol. Diabetes., 104 (3): 284-288.
55. Jellin, J.M., and Gregory, P.J. (2007). Pharmacist’s Letter/Prescriber’s Letter Natural Medicines Comprehensive Database. 9th ed. Stockton, CA: Therapeutic Research Faculty.
56. Jiang, Q., Chrieten, S., Shigenaga, M.K., and Ames, B.N. (2001). γ-Tocopherol, the major form of Vitamin E in the US diet deserves more attention. Ame. Soc. Clinic. Nutri., 74 (6): 714-722.
57. Johnson, M.A., Smith, M.M., and Edmonds, J.T. (1998). Copper, iron, zinc, and manganese in Dietary supplements, infant formulas, and ready-to-eat breakfast cereals. Ame. J. Clinic. Nutri., 1035-1040.
58. Kaczmar, T. (1998). Herbal support for diabetes management. Clinical Nutrition Insights CNI608 5/98, Vol. 6, No.8.
59. Kearney, P.M., Whelton, M., Reynolds, K., Muntner, P., Whelton, P.K., and He, J. (2005). Global burden of hypertension: analysis of worldwide data. Lancet., 365:217-223.
60. Khan, A., Safdar, M., Ali Khan, M.M., Khattak, K.N., and Anderson, R.A. 2003. Cinnamon improves glucose and lipids of people with type 2 diabetes. Diabetes Care 26:3215-3218.
61. Kim, J.A., Formoso, G., Li, Y., Potenza, M.A., Marasciulo, F.L., Montagnani, M., and Quon, M.J. (2007). Epigallocatechin gallate, a green tea polyphenol, mediates NO-dependent vasodilation using signaling pathways in vascular endothelium requiring reactive oxygen species and Fyn. J. Bio. Chem., 282(18):13736-13745.
62. Knentz, A.J., and Nattras, M. (1991). Diabetic ketoacidosis, non ketotic hyperosmolar coma and lactic Acidosis. In: Handbook of diabetes (Pickup JC and Williams, G,eds) (2nd edition). Blackwell Science, pp.479-494.
63. Konrad, T., Vicini, P., Kusterer, K., Hoflich, A., Assadkhani, A., Bohles, H.J., Sewell, A., Tritschler, H.J., Cobelli, C., and Usadel, K.H. (1999) α-Lipoic acid treatment decreases serum lactate and pyruvate concentrations and improves glucose effectiveness in lean and obese patients with type 2 diabetes. Dia Care., 22:280– 287.
64. Kotchen, T.A., and McCarron, D.A. (1998). Dietary electrolytes and blood pressure: A statement For Healthcare Professionals from the American Heart Association Nutrition Committee. Circulation., 98:613-617.
65. Kotchen, J.M., McKean, H.E., and Kotchen, T.A. (1982). Blood pressure trends with aging. Hypertension., 4:128-134.
66. Kumar, P.J., and Clark, M. (2002). Textbook of clinical medicine. Saunders, London, pp 1099-1121.
67. Larsson, S.C., and Wolk, A. (2007). Magnesium intake and risk of type 2 diabetes: a meta-analysis. J. Intern. Med., 262(2):208-214.
68. Litovitz, T.L., Klein-Schwartz, W., White, S., Cobaugh, D.J., Youniss, J., Omslaer, J.C., Drab A., and Benson, B.E. (2001). 2000 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Ame J. Emergency Med., 19:337-395.
69. Mackenzie, T., Leary, L., and Brooks, W.B. (2007). The effect of an extract of green and black tea on glucose control in adults with type 2 diabetes mellitus: double-blind randomized study. Metabol., 56(10):1340-1344.
70. Mangoni, A.A., Sherwood, R.A., Swift, C.G., and Jackson, S.H. (2002). Folic acid enhances endothelial function and reduces blood pressure in smokers: a randomized controlled trial. J. Internal Med., 252:497-503.
71. Mansoor, G.A. (2001). Herbs and alternative therapies in the hypertension clinic. American J. Hyperten., 14: 971-975.
72. Marchioli, R., Barzi, F., Bomba, E., Chieffo, C., Di Gregorio, D., Di Mascio, R., Franzosi, M.G., Geraci, E., Levantesi, G., Maggioni, A.P., Mantini, L., Marfisi, R.M., Mastrogiuseppe, G., Mininni, N., Nicolosi, G.L., Santini, M., Schweiger, C., Tavazzi, L., Tognoni, G., Tucci, C., Valagussa, F., and GISSI-Prevenzione Investigators. (2002). Early Protection against death by n-3 polyunsaturated fatty acid after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo studio della Sopravvienza nell’Infarto Miocardico (GISSI)-Prevenzione. Circulation, 105: 1897-1903.
73. Martin, J., Wang, Z.Q., Zhang, X.H., Wachtel, D., Volaufova, J., Mathews, D.E., and Cefalu, W.T. (2006). Chromium picolinate supplementation attenuates body weight gain and Increases insulin sensitivity in subjects with type 2 diabetes. Dia Care., 29 (8):1826-1832.
74. McCarron, D.A. (1997). Role of adequate dietary calcium intake in the prevention and management of salt-sensitive hypertension. Am. J. Clinic Nutri., 65:712-716.
75. McCarty, M.F. (1999). High-dose biotin, an inducer of glucokinase expression, may synergize With chromium picolinate to enable a definitive nutritional therapy for type II diabetes. Med. Hypotheses., 52: 401-406.
76. McCormick, D. (2006). Vitamin B6. In: Bowman B, Russell R, eds. Present Knowledge in Nutrition. 9th ed. Washington, DC: International Life Sciences Institute.
77. Merchant, R.E., and Andre, C.A. (2001). Nutritional supplement Chlorella pyrenoidosa in the treatment of fibromyalgia, hypertension and ulcerative colitis. Alternative Therapies in Health and Medicine., 7(3): 79-91.
78. Mohamadi, A., Jarrell, S.T., Shi, S.J., Andrawis, N.S., Myers, A., Clouatre, D., and Preuss, H.G. (2000). Effects of wild versus cultivated garlic on blood pressure and other parameters in hypertensive rats. Heart Dis., 2:3-9.
79. Moller, D. E. and Flier, J. S. (1991). “Insulin resistance-mechanisms, syndromes, and implications,” The New England J. Med., 325 (13): 938–948, 1991.
80. Morris, M.C., Evans, D.A., Bienias, J.L., Tangney, C.C., Bennett, C.C., and Aggarwal, N. (2002). Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community study. J. Am. Med. Ass., 287:3230-3237.
81. Mukherjee, B., Anbazhagan, S., Roy, A., Ghosh, R., and Chatterjee, M. (1998). Novel implications of the potential role of selenium on antioxidant status in streptozotocin induced diabetic mice. Biomed. Pharmacother., 52(2):89-95.
82. Ness, A.R., Chee, D., and Elliott, P. (1997). Vitamin C and blood pressure: an overview. J. Human Hyperten., 11:343-350. National Institutes of Health Office of Dietary Supplements: Dietary supplement fact sheet: chromium[article online]. Available fromhttp://ods.od.nih.gov/factsheets/chromium.asp#en35. Accessed 19 February 2013.
83. Palmer, M.E., and Howland, M.A. (2001). Herbals and dietary supplements. In: Ford M et al, eds. Clinical toxicology. Philadelphia: WB Saunders: 316–31.
84. Palmer, M., and Betz, J. Plants. (2002). In: Goldfrank LR, Flomenbaum NE, Lewin NA, et al, eds. Goldfrank’s toxicologic emergencies 7th edn. New York: McGraw-Hill: 1150–82.
85. Paolisso, G., D’Amore, A., Giugliano, D., Ceriello, A., Varricchio, M., and D’Onofrio, F. (1993). Pharmacologic doses of vitamin E improve insulin action in healthy subjects and non-insulin dependent diabetic patients. Am. J. Clinic. Nutri., 57: 650-656.
86. Paolisso, G., D’Amore, A., Balbi, V., Volpe, C., Galzerano, D., Giugliano, D., Sgambato, S., Varricchio, M., and D’Onofrio, F. (1994). Plasma vitamin C affects glucose homeostasis in healthy subjects and in non-insulin dependent diabetes. Am J. Physiol., 266: 261-268.
87. Paolisso, G., Balbi, V., Volpe, C., Varricchio, G., Gambardella, A., Saccomanno, F., Ammendola, S., Varricchio, M., and D’Onofrio, F. (1995). Metabolic benefits deriving from chronic vitamin C supplementation in aged non-insulin dependent diabetics. J. Am. Coll. Nutr., 14:387–392.
88. Pemberton, J. (2006). "Medical experiments carried out in Sheffield on conscientious objectors to military service during the 1939–45 war". Int. J. Epidemiol., 35 (3): 556-558.
89. Phillips, A.W., and Osborne, J.A. (2000). Survey of alternative and nonprescription therapy use. Am. J. Health Syst. Pharm., 57:1361–1362.
90. Potenza, M.A., Marasciulo, F.L., Tarquinio, M., Tiravanti, E., Colantuono, G., Federici, A., Kim, J.A., Quon, M.J., and Montagnani, M. (2007). EGCG, a green tea polyphenol, improves endothelial function and insulin sensitivity, reduces blood pressure, and protects against myocardial I/R injury in SHR. Am. J. Physiol. Endocrinol. Metab., 292:1378–1387.
91. Preuss, H.G., Jarrell, S.T., Scheckenbach, R., Lieberman, S., and Anderson, R.A. (1998). Comparative Effects of Chromium, Vanadium and Gymnema Sylvestre on Sugar Induced Blood Pressure Elevations in SHR. J. Am. College Nutri., 17 (2): 116-123.
92. Prisco, D., Paniccia, R., Bandinelli, B., Filippini, M., Francalanci, I., Giusti, B., Giuriani L., Gensini G.F., Abbate R., and Neri Serneri G.G. (1998). Effect of medium-term supplementation with a moderate dose of n-3 polyunsaturated fatty acids on blood pressure in mild hypertensive patients. Thromb Res., 91:105–112.
93. Rang, H.P., Dale, M.M., and Ritters, J.M. (1991). The endocrine pancreas and the control of blood glucose, in pharmacology, Simmons, B. and Beasley, S. eds, Longman Group Ltd., UK, pp 403-410.
94. Rasmussen, C.B., Glisson, J.K., and Minor, D.S. (2012). Dietary Supplements and HypertensionPot ential Benefits and Precautions-A review. The J. Clinical. Hyperten., 14(7):467-471.
95. Reljanovic, M., Reichel, G., Rett, K., Lobisch, M., Schuette, K., Moller, W., Tritschler, H.J., and Mehnert, H. (1999).Treatment of diabetic polyneuropathy with the antioxidantthioctic acid (alpha-lipoic acid): a two year multicenter randomized double blind placebo controlled trial. Free. Radic. Biol. Med., 31:171-179.
96. Rother, K.I. (2007). "Diabetes Treatment-Bridging the Divide". N. Engl. J. Med., 356 (15): 1499-1501.
97. Ryu, O.H., Lee, J., Lee, K.W., Kim, H.Y., Seo, J.A., Kim, S.G., Kim, N.H., Baik, S.H., Choi, D.S., and Choi, K.M. (2006). Effects of green tea consumption on inflammation, insulin resistance and pulse wave velocity in type 2 diabetes patients. Diabetes. Res. Clinic. Practice., 71(3):356-358.
98. Salardi, S., Cacciari, E., Sassi, S., Grossi, G., Mainetti, B., Casa, C.D., Pirazzoli, P., Cicognani, A., and Gualandi, S. (2000). Homocysteinemia, serum folate and vitamin B12 in very young patients with diabetes mellitus type 1. J. Pediatr. Endocrinol. Metab., 13:1621-1627.
99. Schaumburg, H., Kaplan, J., Windebank, A., Vick, N., Rasmus, S., Pleasure, D., and Brown, M.J. (1983). Sensory neuropathy from pyridoxine abuse. A new megavitamin syndrome. New Engl. J. Med., 309: 445-448.
100. Schulze, M.B., Schulz, M., Heidemann, C., Schienkiewitz, A., Hoffmann, K., and Boeing, H. (2007). Fiber and magnesium intake and incidence of type 2 diabetes: a prospective study and meta-analysis, Archives Intern. Med., 167 (9): 956–965.
101. Sharma, A.K. (1993). Diabetes mellitus and its complications: An update. Galadari EO, Behara I, Manchandra M, Abdulrazzaq SK, Mehra MK (eds) Macmillian, New Delhi.
102. Sheela, C.G., and Augusti, K.T. (1992). Antidiabetic effects of S-ally cysteine sulphoxide isolated from garlic Allium sativum Linn. Ind. J. Experiment. Bio., 30:523-526.
103. Singh, R.B., Sul, I.L., Singh, V.P., Chaithiraphan, S., Laothavorn, P., Sy, R.G., Babilonia, N.A., Rahman, A.R.A., Sheikh, S., Tomlinson, B., and Sarraf-Zadigan, N. (2000). Hypertension and stroke in Asia: prevalence, control and strategies in developing countries for prevention. J. Human Hyperten., 14: 749-763.
104. Singh, R.B., Niaz, M.A., Rastogi, S.S., Shukla P.K., and Thakur A.S. (1999). Effect of hydrosoluble coenzyme Q10 on blood pressures and insulin resistance in hypertensive patients with coronary artery disease. J. Hum. Hypertens., 13:203–208.
105. Sitasawad, S., Deshpande, M., Katdare, M., Tirth, S., and Parab, P. (2001). Beneficial effect of supplementation with copper sulfate on STZ-diabetic mice (IDDM). Diabetes. Res. Clin. Pract., 52: 77-84.
106. Soetan, K.O., Olaiya, C.O. and Oyewole, O.E. (2010). The importance of mineral elements for humans, domestic animals and plants; A review. Afr. J. Food. Sci., 4 (5): 200-222.
107. Spence, J.D. (1996). Cerebral consequences of hypertension: Where do they lead? J. Hypertens. Suppl.14: S139–S145.
108. Spencer, J. (2004). The risk of mixing drugs and herbs. Wall Street Journal June 22, 2004:D1.
109. Stapleton, S.R. (2000). Selenium: an insulin-mimetic. Cell. Mol. Life. Sci., 57:1874-1879.
110. Sunmonu, T.O., and Afolayan, A.J. (2013). Evaluation of Antidiabetic Activity and Associated Toxicity of Artemisia afra Aqueous Extract in Wistar Rats. Evidence-Based. Complementary andAlternative Medicine. Volume 2013 Article ID 929074, 8 pages
111. Tabassum, N. and Ahmad, F. (2011). Role of natural herbs in the treatment of hypertension. Pharmacog. Rev., 5:30-40.
112. Timbo, B.B., Ross, M.P., McCarthy, P.V., and Lin, C.J. (2006). Dietary supplements in a National Survey: Prevalence of Use and Reports of Adverse Events. J. Am. Diet. Ass., 106:1966-1974.
113. Touyz, R.M. (1991). Magnesium supplementation as an adjuvant to synthetic calcium channel antagonists in the treatment of hypertension. Med. Hypotheses., 36: 140-141.
114. Trofimiuk, E, Braszko, J.J. (2011). Long-term administration of cod liver oil ameliorates cognitive impairment induced by chronic stress in rats. Lipids., 46(5): 417-423.
115. Van Breemen, R.B., Fong, H.H., and Farnsworth, N.R. (2007). The role of quality assurance and standardization in the safety of botanical dietary supplements. Chem. Res. Toxicol., 20:577-582.
116. Van Dijk, R.A., Rauwerda, J.A., Steyn, M., Twisk, J.W., and Stehouwer. C.D. (2001). Long-term homocysteine-lowering treatment with folic acid plus pyridoxine is associated with decreased blood pressure but not with improved brachial artery endothelium-dependent vasodilation or carotid artery stiffness: a 2-year, randomized, placebo-controlled trial. Arteriole. Thrombo. Vas. Bio., 21: 2072-2079.
117. Vasdev, S., Longerich, L., Gill, V., and Singal, P. (2002). Dietary management of hypertension. Kuwait Med. Journ., 34 (1) 2-11.
118. Warner, M.G. (2000). Complementary and alternative therapies for hypertension. Complementary Health Practice Review 6:11-19.
119. Weiss, D. (2000). Cardiovascular disease: risk factors and fundamental nutrition. International J. Integra. Med., 2: 6-12.
120. World Health Organization Department of Non-communicable Disease Surveillance (1999). Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications (PDF).
121. World Health Organization. (2002). Integrated management of cardiovascular risk. Geneva:
122. WHO, (2002). http://whqlibdoc.who.int/publications/9241562242.pdf (accessed 20 June, 2012).
123. World Health Organisation. (2003). The world health report 2003. International Society of Hypertension (ISH) statement on management of hypertension. J. Hyper., 21: 1983-1992
124. Wild, S., Roglic, G. Green, Sicree, R., and King, H. (2004). “Global prevalence of diabetes: estimates for the year 2000 and projections for 2030,” Diabetes Care, vol. 27, no. 5, pp. 1047-1053.
125. Winslow, L.C., and Kroll, D.J. (1998). Herbs as medicine. Arch. Intern. Med., 158: 2192-2199.
126. Wise, E. (2004). Twelve dangerous dietary supplements identified by ‘Consumer Reports’ widely used herbs linked to several serious ailments. USA Today, April 8, 9D.
127. www.wikipedia.org. Dietery supplement Retrieved 14/102/2014.
128. Yosefy, C., Viskoper, J.R., Laszt, A, Priluk R., Guita E., Varon D., Illan Z., Berry E.M., Savion N., Adan, Y., Lugassy, G., Schneider R., and Raz, A. (1999). The effects of fish oil on hypertension, plasma lipids and hemostatis in hypertensive, obese yslipidemic patients with and without diabetes mellitus. Prostaglandins Leukot Essent Fatty Acids., 61:83-87.
129. Yusuf, S., Reddy, S., Ounpuu, S., and Anand, S. (2001). Global burden of cardiovascular diseases. Part 1: General considerations, the epidemiologic transition risk factors and impact of urbanization. Circulation., 104: 2746-2753.
130. Ziegler, D., Hanefeld, M., Ruhnau, K.J., Meibner, H.P., Lobisch, M., Schuette, K., and Gries, F.A. (1995). Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant “lipoic acid”: a 3 week multicentre randomized controlled trial (ALADIN Study I). Diabetologia 38:1425-1433.